New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies Jan. 9, 1998 No Comments
Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity Jan. 2, 1998 No Comments
RSS